Insideraktier | 7 292 946 shares |
Insider Sentiment Score
Insider sentiment score hittar de företag som köps av foretagsinsynspersoner.
Det är resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av insiderackumulation. Poängmodellen använder en kombination av nettoantalet insiders som köpt de föregående 90 dagarna, det totala antalet aktier som köpts i procent av aktiekapitalet och det totala antalet aktier som ägs av insiders. Siffran sträcker sig från 0 till 100, med högre siffror som indikerar en högre nivå av ackumulering för sina kamrater, och 50 är genomsnittet.
Uppdateringsfrekvens: Dagligen
Se Insiders Top Picks, som ger en lista över företag med högsta insiderackumulation.
Office Sentiment Score
Officersentiment Score hittar företag som köps av Corporate Officers.
Per definition Corporate Officers är Corporate Insiders, men till skillnad från vissa av de andra Insiders (10 % aktieägare och styrelseledamöter), arbetar ämbetsmän för företaget dagligen och de använder sina egna pengar när de handlar . (10 % aktieägare och styrelseledamöter är ofta fondförvaltare som förvaltar andras pengar.) Som sådan är insideraffärer som görs av tjänstemän mycket mer betydelsefulla och bör behandlas på lämpligt sätt.
Liksom Insider Sentiment Score är Officer Sentiment Score resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av officersackumulering.
Uppdateringsfrekvens: Dagligen
Se insiderns bästa val, vilket ger en lista över företag med högsta insider sentiment.
Viktiga insidernyckeltal
Denna kort visar hur företaget rankas längs olika insidernyckeltal. Procenttilrankningen visar hur detta företag jämförs med andra företag på USA-marknaden. Högre rankingar indikerar bättre situationer.
Till exempel anses det allmänt att insiderköp är en positiv indikator, så företag med mer insiderköp skulle rankas högre än företag med mindre insiderköp (eller til och med insiderförsäljning).
Nettoantalet insiders som köper (rankning)
N/A
Nettoantalet insiders som köper är den totala mängden insiders som säljer minus det totala antalet insiders som säljer under de senaste 90 dagarna. Percentilrankningen visas här (intervall från 0 till 100%).
Procent av flytande köpta av insiders (ranking)
N/A
Procentandelen av aktier köpta av insiders är det totala antalet aktier som köpts av insiders minus det totala antalet aktier som sålts av insiders under de senaste 90 dagarna, dividerat med det totala antalet aktier och multiplicerat med 100.
Insiderhandelsdiagram
Ocera Therapeutics, Inc. insideraffärer visas i följande diagram. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. I allmänhet är det i allmänhet olagligt för insiders att göra affärer i sina företag baserat på väsentlig, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4.
Insiderlista och lönsamhetsstatistik
Den här tabellen visar listan över kända insiders och genereras automatiskt från anmälningar som avslöjas till SEC. Förutom namnen, den senaste titeln och direktören, tjänstemannen eller ägarbeteckningen på 10 %, tillhandahåller vi de senaste avslöjade innehaven. Dessutom, när det är möjligt tillhandahåller vi insiderns historiska handelsresultat. Det historiska handelsresultatet är ett vägt genomsnitt av resultatet för faktiska köptransaktioner på den öppna marknaden som insidern gjort. För mer information om hur detta beräknas, titta på detta YouTube-webinarium.
See our leaderboard of most profitable insider traders.
Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
---|
Report errors via our new Insider Auditing Tool
Track Records av insiderköp - Kortsiktig vinstanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i OCRX / Ocera Therapeutics, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste köpen på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Track Records av insiderförsäljning - Kortsiktig förlustanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i OCRX / Ocera Therapeutics, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste försäljningarna på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Transaktionshistorik
Klicka på länkikonen för att se hela transaktionshistoriken. Transaktioner som rapporteras som en del av en automatisk handelsplan 10b5-1 kommer att ha ett X i kolumnen markerad 10b-5.
Fil datum |
Handel datum |
Schema | Insider | Ticker | Värdepappertitel | Kod | Direkta | Utövningspris | Enhet pris |
Enheter ändrad |
Värde ändrad (1K) |
Kvarvarande Optioner |
Kvarvarande Aktier |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2017-12-13 | 2017-12-11 | 4 | DP VIII Associates, L.P. | OCRX | Common Stock | D | −7 333 | 0 | ||||||
2017-12-13 | 2017-12-11 | 4 | Domain Partners VI, L.P. | OCRX | Warrant to Purchase Common Stock | D | 0,67 | −20 150 | 0 | |||||
2017-12-13 | 2017-12-11 | 4 | Domain Partners VI, L.P. | OCRX | Warrant to Purchase Common Stock | D | 0,67 | −20 150 | 0 | |||||
2017-12-13 | 2017-12-11 | 4 | Domain Partners VI, L.P. | OCRX | Common Stock | D | −1 857 036 | 0 | ||||||
2017-12-13 | 2017-12-11 | 4 | DP VI Associates, L.P. | OCRX | Common Stock | D | −15 731 | 0 | ||||||
2017-12-13 | 2017-12-11 | 4 | DOMAIN ASSOCIATES | OCRX | Common Stock | D | −47 963 | 0 | ||||||
2017-12-13 | 2017-12-11 | 4 | Domain Partners VIII, L.P. | OCRX | Common Stock | D | −988 285 | 0 | ||||||
2017-12-11 | 2017-12-11 | 4 | WIERENGA WENDALL | OCRX | Stock Option (Right to Buy) | D | 2,26 | −12 500 | 0 | |||||
2017-12-11 | 2017-12-11 | 4 | WIERENGA WENDALL | OCRX | Stock Option (Right to Buy) | D | 7,84 | −10 000 | 0 | |||||
2017-12-11 | 2017-12-11 | 4 | WIERENGA WENDALL | OCRX | Stock Option (Right to Buy) | D | 3,76 | −10 000 | 0 | |||||
2017-12-11 | 2017-12-11 | 4 | WIERENGA WENDALL | OCRX | Stock Option (Right to Buy) | D | 13,25 | −20 000 | 0 | |||||
2017-12-11 | 2017-12-11 | 4 | WIERENGA WENDALL | OCRX | Common Stock | D | 1,5200 | −12 500 | −19 | 0 | ||||
2017-12-11 | 2017-12-11 | 4 | WIERENGA WENDALL | OCRX | Common Stock | D | 1,5200 | −5 000 | −8 | 0 | ||||
2017-12-11 | 2017-12-11 | 4 | WEBER ECKARD | OCRX | Stock Option (Right to Buy) | D | 2,26 | −12 500 | 0 | |||||
2017-12-11 | 2017-12-11 | 4 | WEBER ECKARD | OCRX | Stock Option (Right to Buy) | D | 7,84 | −10 000 | 0 | |||||
2017-12-11 | 2017-12-11 | 4 | WEBER ECKARD | OCRX | Stock Option (Right to Buy) | D | 3,76 | −10 000 | 0 | |||||
2017-12-11 | 2017-12-11 | 4 | WEBER ECKARD | OCRX | Stock Option (Right to Buy) | D | 7,85 | −20 000 | 0 | |||||
2017-12-11 | 2017-12-11 | 4 | WEBER ECKARD | OCRX | Stock Option (Right to Buy) | D | 1,84 | −2 992 | 0 | |||||
2017-12-11 | 2017-12-11 | 4 | WEBER ECKARD | OCRX | Stock Option (Right to Buy) | D | 1,84 | −2 992 | 0 | |||||
2017-12-11 | 2017-12-11 | 4 | WEBER ECKARD | OCRX | Common Stock | D | 1,5200 | −12 500 | −19 | 0 | ||||
2017-12-11 | 2017-12-11 | 4 | WEBER ECKARD By Trust | OCRX | Common Stock | I | 1,5200 | −11 969 | −18 | 0 | ||||
2017-12-11 | 2017-12-11 | 4 | WEBER ECKARD By Trust | OCRX | Common Stock | I | 1,5200 | −344 719 | −524 | 0 | ||||
2017-12-11 | 2017-12-11 | 4 | VANLENT ANNE | OCRX | Stock Option (Right to Buy) | D | 3,76 | −10 000 | 0 | |||||
2017-12-11 | 2017-12-11 | 4 | VANLENT ANNE | OCRX | Stock Option (Right to Buy) | D | 7,84 | −10 000 | 0 | |||||
2017-12-11 | 2017-12-11 | 4 | VANLENT ANNE | OCRX | Stock Option (Right to Buy) | D | 50,88 | −2 652 | 0 | |||||
2017-12-11 | 2017-12-11 | 4 | VANLENT ANNE | OCRX | Stock Option (Right to Buy) | D | 48,00 | −2 083 | 0 | |||||
2017-12-11 | 2017-12-11 | 4 | VANLENT ANNE | OCRX | Stock Option (Right to Buy) | D | 7,85 | −20 000 | 0 | |||||
2017-12-11 | 2017-12-11 | 4 | VANLENT ANNE | OCRX | Stock Option (Right to Buy) | D | 2,26 | −12 500 | 0 | |||||
2017-12-11 | 2017-12-11 | 4 | VANLENT ANNE | OCRX | Common Stock | D | 1,5200 | −12 500 | −19 | 0 | ||||
2017-12-11 | 2017-12-11 | 4 | Dere Willard H | OCRX | Stock Option (Right to Buy) | D | 2,42 | −20 000 | 0 | |||||
2017-12-11 | 2017-12-11 | 4 | Dere Willard H | OCRX | Common Stock | D | 1,5200 | −12 500 | −19 | 0 | ||||
2017-12-11 | 2017-12-11 | 4 | Byrnes Michael | OCRX | Stock Option (Right to Buy) | D | 7,50 | −70 000 | 0 | |||||
2017-12-11 | 2017-12-11 | 4 | Byrnes Michael | OCRX | Stock Option (Right to Buy) | D | 2,15 | −102 300 | 0 | |||||
2017-12-11 | 2017-12-11 | 4 | Byrnes Michael | OCRX | Stock Option (Right to Buy) | D | 3,76 | −75 000 | 0 | |||||
2017-12-11 | 2017-12-11 | 4 | Byrnes Michael | OCRX | Stock Option (Right to Buy) | D | 7,50 | −55 000 | 0 | |||||
2017-12-11 | 2017-12-11 | 4 | Byrnes Michael | OCRX | Stock Option (Right to Buy) | D | 2,98 | −123 300 | 0 | |||||
2017-12-11 | 2017-12-11 | 4 | Byrnes Michael | OCRX | Common Stock | D | 1,5200 | −150 000 | −228 | 0 | ||||
2017-12-11 | 2017-12-11 | 4 | Byrnes Michael | OCRX | Common Stock | D | 1,5200 | −13 000 | −20 | 0 | ||||
2017-12-11 | 2017-12-11 | 4 | James Steven P | OCRX | Stock Option (Right to Buy) | D | 2,26 | −12 500 | 0 | |||||
2017-12-11 | 2017-12-11 | 4 | James Steven P | OCRX | Stock Option (Right to Buy) | D | 3,76 | −10 000 | 0 | |||||
2017-12-11 | 2017-12-11 | 4 | James Steven P | OCRX | Stock Option (Right to Buy) | D | 5,51 | −20 000 | 0 | |||||
2017-12-11 | 2017-12-11 | 4 | James Steven P | OCRX | Common Stock | D | 1,5200 | −12 500 | −19 | 0 | ||||
2017-12-11 | 2017-12-11 | 4 | Bukofzer Stan | OCRX | Stock Option (Right to Buy) | D | 2,15 | −208 350 | 0 | |||||
2017-12-11 | 2017-12-11 | 4 | Bukofzer Stan | OCRX | Stock Option (Right to Buy) | D | 3,06 | −300 000 | 0 | |||||
2017-12-11 | 2017-12-11 | 4 | Bukofzer Stan | OCRX | Common Stock | D | 1,5200 | −200 000 | −304 | 0 | ||||
2017-12-11 | 2017-12-11 | 4 | Bukofzer Stan | OCRX | Common Stock | D | 1,5200 | −2 500 | −4 | 0 | ||||
2017-12-11 | 2017-12-11 | 4 | Kjellson Nina S | OCRX | Stock Option (Right to Buy) | D | 2,26 | −12 500 | 0 | |||||
2017-12-11 | 2017-12-11 | 4 | Kjellson Nina S | OCRX | Stock Option (Right to Buy) | D | 3,76 | −10 000 | 0 | |||||
2017-12-11 | 2017-12-11 | 4 | Kjellson Nina S | OCRX | Stock Option (Right to Buy) | D | 7,84 | −10 000 | 0 | |||||
2017-12-11 | 2017-12-11 | 4 | Kjellson Nina S | OCRX | Stock Option (Right to Buy) | D | 7,85 | −20 000 | 0 | |||||
2017-12-11 | 2017-12-11 | 4 | Kjellson Nina S | OCRX | Common Stock | D | 1,5200 | −12 500 | −19 | 0 | ||||
2017-12-11 | 2017-12-11 | 4 | Grais Linda S | OCRX | Stock Option (Right to Buy) | D | 0,67 | −11 969 | 0 | |||||
2017-12-11 | 2017-12-11 | 4 | Grais Linda S | OCRX | Stock Option (Right to Buy) | D | 0,67 | −30 827 | 0 | |||||
2017-12-11 | 2017-12-11 | 4 | Grais Linda S | OCRX | Stock Option (Right to Buy) | D | 0,67 | −30 826 | 0 | |||||
2017-12-11 | 2017-12-11 | 4 | Grais Linda S | OCRX | Stock Option (Right to Buy) | D | 7,84 | −37 500 | 0 | |||||
2017-12-11 | 2017-12-11 | 4 | Grais Linda S | OCRX | Stock Option (Right to Buy) | D | 7,38 | −491 550 | 0 | |||||
2017-12-11 | 2017-12-11 | 4 | Grais Linda S | OCRX | Stock Option (Right to Buy) | D | 3,76 | −160 000 | 0 | |||||
2017-12-11 | 2017-12-11 | 4 | Grais Linda S | OCRX | Stock Option (Right to Buy) | D | 2,98 | −348 600 | 0 | |||||
2017-12-11 | 2017-12-11 | 4 | Grais Linda S | OCRX | Stock Option (Right to Buy) | D | 2,15 | −289 200 | 0 | |||||
2017-12-11 | 2017-12-11 | 4 | Grais Linda S | OCRX | Common Stock | D | 1,5200 | −70 000 | −106 | 0 | ||||
2017-12-11 | 2017-12-11 | 4 | Grais Linda S | OCRX | Common Stock | D | 1,5200 | −230 000 | −350 | 0 | ||||
2017-06-22 | 2017-06-20 | 4 | VANLENT ANNE | OCRX | Common Stock | D | 12 500 | 12 500 | ||||||
2017-06-22 | 2017-06-20 | 4 | Kjellson Nina S | OCRX | Common Stock | D | 12 500 | 12 500 | ||||||
2017-06-22 | 2017-06-20 | 4 | WEBER ECKARD | OCRX | Common Stock | D | 12 500 | 12 500 | ||||||
2017-06-22 | 2017-06-20 | 4 | James Steven P | OCRX | Common Stock | D | 12 500 | 12 500 | ||||||
2017-06-22 | 2017-06-20 | 4 | WIERENGA WENDALL | OCRX | Common Stock | D | 12 500 | 17 500 | ||||||
2017-06-22 | 2017-06-20 | 4 | Dere Willard H | OCRX | Common Stock | D | 12 500 | 12 500 | ||||||
2017-03-30 | 2017-03-29 | 4 | Grais Linda S | OCRX | Common Stock | D | 230 000 | 300 000 | ||||||
2017-03-30 | 2017-03-29 | 4 | Bukofzer Stan | OCRX | Common Stock | D | 200 000 | 202 500 | ||||||
2017-03-30 | 2017-03-29 | 4 | Byrnes Michael | OCRX | Common Stock | D | 150 000 | 163 000 | ||||||
2017-03-28 | 2017-03-28 | 4 | Byrnes Michael | OCRX | Common Stock | D | 1,2848 | 3 000 | 4 | 13 000 | ||||
2016-12-30 | 2016-10-31 | 4 | POWELL MICHAEL | OCRX | Common Stock | I | 14 328 | 14 328 | ||||||
2016-12-30 | 2016-10-31 | 4 | POWELL MICHAEL | OCRX | Common Stock | I | −9 540 | 0 | ||||||
2016-12-30 | 2016-10-31 | 4 | POWELL MICHAEL | OCRX | Common Stock | I | −138 686 | 0 | ||||||
2016-12-30 | 2016-10-31 | 4 | POWELL MICHAEL | OCRX | Common Stock | I | −699 996 | 0 | ||||||
2016-12-30 | 2016-09-12 | 4 | POWELL MICHAEL | OCRX | Stock warrant (right to buy) | I | 0,67 | −125 | 0 | |||||
2016-12-30 | 2016-09-12 | 4 | POWELL MICHAEL | OCRX | Stock warrant (right to buy) | I | 0,67 | −125 | 0 | |||||
2016-12-30 | 2016-09-12 | 4 | POWELL MICHAEL | OCRX | Stock warrant (right to buy) | I | 0,67 | −1 820 | 0 | |||||
2016-12-30 | 2016-09-12 | 4 | POWELL MICHAEL | OCRX | Stock warrant (right to buy) | I | 0,67 | −1 820 | 0 | |||||
2016-12-30 | 2016-09-12 | 4 | POWELL MICHAEL | OCRX | Stock warrant (right to buy) | I | 0,67 | −9 187 | 0 | |||||
2016-12-30 | 2016-09-12 | 4 | POWELL MICHAEL | OCRX | Stock warrant (right to buy) | I | 0,67 | −9 187 | 0 | |||||
2016-12-30 | 2016-09-12 | 4 | POWELL MICHAEL | OCRX | Common Stock | I | 2,2920 | −74 | −0 | 9 540 | ||||
2016-12-30 | 2016-09-12 | 4 | POWELL MICHAEL | OCRX | Common Stock | I | 2,2920 | −1 066 | −2 | 138 686 | ||||
2016-12-30 | 2016-09-12 | 4 | POWELL MICHAEL | OCRX | Common Stock | I | 2,2920 | −5 372 | −12 | 699 996 | ||||
2016-12-30 | 2016-09-12 | 4 | POWELL MICHAEL | OCRX | Common Stock | I | 0,6700 | 250 | 0 | 9 614 | ||||
2016-12-30 | 2016-09-12 | 4 | POWELL MICHAEL | OCRX | Common Stock | I | 0,6700 | 3 640 | 2 | 139 752 | ||||
2016-12-30 | 2016-09-12 | 4 | POWELL MICHAEL | OCRX | Common Stock | I | 0,6700 | 18 374 | 12 | 705 368 | ||||
2016-12-16 | 2016-12-15 | 4 | Grais Linda S | OCRX | Stock Option (Right to Buy) | D | 2,15 | 289 200 | 289 200 | |||||
2016-12-16 | 2016-12-15 | 4 | Byrnes Michael | OCRX | Stock Option (Right to Buy) | D | 2,15 | 102 300 | 102 300 | |||||
2016-12-16 | 2016-12-15 | 4 | Bukofzer Stan | OCRX | Stock Option (Right to Buy) | D | 2,15 | 208 350 | 208 350 | |||||
2016-12-08 | 2016-12-07 | 4 | Grais Linda S | OCRX | Common Stock | D | 2,1400 | 7 000 | 15 | 70 000 | ||||
2016-10-28 | 2016-10-26 | 4 | Dere Willard H | OCRX | Stock Option (Right to Buy) | D | 2,42 | 20 000 | 20 000 | |||||
2016-10-17 | 2016-10-13 | 4 | Bukofzer Stan | OCRX | Common Stock | D | 2,6390 | 2 500 | 7 | 2 500 | ||||
2016-07-13 | 2016-07-11 | 4 | POWELL MICHAEL | OCRX | Stock Option (Right to Buy) | D | 1,26 | −11 969 | 0 | |||||
2016-07-13 | 2016-07-11 | 4 | POWELL MICHAEL | OCRX | Common Stock | D | 1,2600 | 11 969 | 15 | 11 969 | ||||
2016-06-15 | 2016-06-14 | 4 | WIERENGA WENDALL | OCRX | Stock Option (Right to Buy) | D | 2,26 | 12 500 | 12 500 | |||||
2016-06-15 | 2016-06-14 | 4 | VANLENT ANNE | OCRX | Stock Option (Right to Buy) | D | 2,26 | 12 500 | 12 500 | |||||
2016-06-15 | 2016-06-14 | 4 | POWELL MICHAEL | OCRX | Stock Option (Right to Buy) | D | 2,26 | 12 500 | 12 500 | |||||
2016-06-15 | 2016-06-14 | 4 | James Steven P | OCRX | Stock Option (Right to Buy) | D | 2,26 | 12 500 | 12 500 | |||||
2016-06-15 | 2016-06-14 | 4 | WEBER ECKARD | OCRX | Stock Option (Right to Buy) | D | 2,26 | 12 500 | 12 500 | |||||
2016-06-15 | 2016-06-14 | 4 | Kjellson Nina S | OCRX | Stock Option (Right to Buy) | D | 2,26 | 12 500 | 12 500 | |||||
2016-03-07 | 2016-03-04 | 4 | Grais Linda S | OCRX | Common Stock | D | 3,1900 | 3 000 | 10 | 63 000 | ||||
2016-01-25 | 2016-01-22 | 4 | Grais Linda S | OCRX | Common Stock | D | 2,3800 | 10 000 | 24 | 60 000 | ||||
2016-01-19 | 2016-01-15 | 4 | Byrnes Michael | OCRX | Common Stock | D | 2,0700 | 3 500 | 7 | 10 000 | ||||
2016-01-19 | 2016-01-15 | 4 | Aggarwal Gaurav | OCRX | Common Stock | D | 2,1500 | 10 000 | 22 | 20 000 | ||||
2016-01-19 | 2016-01-15 | 4 | Grais Linda S | OCRX | Common Stock | D | 2,0800 | 10 000 | 21 | 50 000 | ||||
2016-01-07 | 2016-01-06 | 4 | Aggarwal Gaurav | OCRX | Stock Option (Right to Buy) | D | 2,98 | 49 325 | 49 325 | |||||
2016-01-07 | 2016-01-06 | 4 | Aggarwal Gaurav | OCRX | Stock Option (Right to Buy) | D | 2,98 | 147 975 | 147 975 | |||||
2016-01-07 | 2016-01-06 | 4 | Grais Linda S | OCRX | Stock Option (Right to Buy) | D | 2,98 | 116 200 | 116 200 | |||||
2016-01-07 | 2016-01-06 | 4 | Grais Linda S | OCRX | Stock Option (Right to Buy) | D | 2,98 | 348 600 | 348 600 | |||||
2016-01-07 | 2016-01-05 | 4 | Bukofzer Stan | OCRX | Stock Option (Right to Buy) | D | 3,06 | 100 000 | 100 000 | |||||
2016-01-07 | 2016-01-05 | 4 | Bukofzer Stan | OCRX | Stock Option (Right to Buy) | D | 3,06 | 300 000 | 300 000 | |||||
2016-01-07 | 2016-01-06 | 4 | Byrnes Michael | OCRX | Stock Option (Right to Buy) | D | 2,98 | 41 100 | 41 100 | |||||
2016-01-07 | 2016-01-06 | 4 | Byrnes Michael | OCRX | Stock Option (Right to Buy) | D | 2,98 | 123 300 | 123 300 | |||||
2016-01-06 | 2016-01-04 | 4 | WEBER ECKARD | OCRX | Stock Option (Right to Buy) | D | 0,92 | 11 969 | 0 | |||||
2016-01-06 | 2016-01-04 | 4 | WEBER ECKARD | OCRX | Common Stock | D | −11 969 | 344 719 | ||||||
2016-01-06 | 2016-01-04 | 4 | WEBER ECKARD | OCRX | Common Stock | D | 0,9200 | 11 969 | 11 | 356 688 | ||||
2015-12-18 | 3 | Shah Nimesh By Domain Associates, LLC | OCRX | Common Stock | I | 95 926 | ||||||||
2015-12-18 | 3 | Shah Nimesh By Domain Associates, LLC | OCRX | Common Stock | I | 95 926 | ||||||||
2015-06-24 | 2015-06-23 | 4 | WIERENGA WENDALL | OCRX | Common Stock | D | 3,7100 | 5 000 | 19 | 5 000 | ||||
2015-06-22 | 2015-06-18 | 4 | WIERENGA WENDALL | OCRX | Stock Option (Right to Buy) | D | 3,76 | 10 000 | 10 000 | |||||
2015-06-22 | 2015-06-18 | 4 | POWELL MICHAEL | OCRX | Stock Option (Right to Buy) | D | 3,76 | 10 000 | 10 000 | |||||
2015-06-22 | 2015-06-18 | 4 | James Steven P | OCRX | Stock Option (Right to Buy) | D | 3,76 | 10 000 | 10 000 | |||||
2015-06-22 | 2015-06-18 | 4 | VANLENT ANNE | OCRX | Stock Option (Right to Buy) | D | 3,76 | 10 000 | 10 000 | |||||
2015-06-22 | 2015-06-18 | 4 | WEBER ECKARD | OCRX | Stock Option (Right to Buy) | D | 3,76 | 10 000 | 10 000 | |||||
2015-06-22 | 2015-06-18 | 4 | Kjellson Nina S | OCRX | Stock Option (Right to Buy) | D | 3,76 | 10 000 | 10 000 | |||||
2015-06-22 | 2015-06-18 | 4 | Grais Linda S | OCRX | Stock Option (Right to Buy) | D | 3,76 | 160 000 | 160 000 | |||||
2015-06-22 | 2015-06-18 | 4 | Aggarwal Gaurav | OCRX | Stock Option (Right to Buy) | D | 3,76 | 75 000 | 75 000 | |||||
2015-06-22 | 2015-06-18 | 4 | Byrnes Michael | OCRX | Stock Option (Right to Buy) | D | 3,76 | 75 000 | 75 000 | |||||
2015-05-07 | 2015-05-07 | 4 | Patni Rajiv | OCRX | Common Stock | D | 3,9700 | 5 050 | 20 | 5 050 | ||||
2015-05-06 | 2015-05-06 | 4 | Grais Linda S | OCRX | Common Stock | D | 3,7300 | 30 000 | 112 | 40 000 | ||||
2015-05-06 | 2015-05-06 | 4 | Aggarwal Gaurav | OCRX | Common Stock | D | 3,6200 | 7 500 | 27 | 10 000 | ||||
2015-05-06 | 2015-05-06 | 4 | Byrnes Michael | OCRX | Common Stock | D | 3,6100 | 2 500 | 9 | 6 500 | ||||
2014-12-04 | 2014-12-02 | 4 | Byrnes Michael | OCRX | Stock Option (Right to Buy) | D | 7,50 | 70 000 | 70 000 | |||||
2014-10-02 | 2014-10-01 | 4 | Byrnes Michael | OCRX | Common Stock | D | 4,8100 | 2 000 | 10 | 4 000 | ||||
2014-09-22 | 3 | Byrnes Michael | OCRX | Common Stock | D | 4 000 | ||||||||
2014-09-22 | 3 | Byrnes Michael | OCRX | Common Stock | D | 4 000 | ||||||||
2014-09-18 | 2014-09-17 | 4 | James Steven P | OCRX | Stock Option (Right to Buy) | D | 5,51 | 20 000 | 20 000 | |||||
2014-09-02 | 2014-09-02 | 4 | Patni Rajiv | OCRX | Stock Option (Right to Buy) | D | 6,03 | 20 000 | 20 000 | |||||
2014-09-02 | 2014-09-02 | 4 | Patni Rajiv | OCRX | Stock Option (Right to Buy) | D | 6,03 | 20 000 | 20 000 | |||||
2014-09-02 | 2014-09-02 | 4 | Patni Rajiv | OCRX | Stock Option (Right to Buy) | D | 6,03 | 250 000 | 250 000 | |||||
2014-07-15 | 2014-07-11 | 4 | TETLOW SHARON | OCRX | Common Stock | D | 5,8290 | 3 000 | 17 | 3 000 | ||||
2014-07-15 | 2014-07-11 | 4 | Grais Linda S | OCRX | Common Stock | D | 5,9280 | 10 000 | 59 | 10 000 | ||||
2014-06-20 | 2014-06-11 | 4 | WEBER ECKARD | OCRX | Stock Option (Right to Buy) | D | 7,84 | 10 000 | 10 000 | |||||
2014-06-13 | 2014-06-11 | 4 | VANLENT ANNE | OCRX | Stock Option (Right to Buy) | D | 7,84 | 10 000 | 10 000 | |||||
2014-06-13 | 2014-06-11 | 4 | POWELL MICHAEL | OCRX | Stock Option (Right to Buy) | D | 7,84 | 10 000 | 10 000 | |||||
2014-06-13 | 2014-06-11 | 4 | WIERENGA WENDALL | OCRX | Stock Option (Right to Buy) | D | 7,84 | 10 000 | 10 000 | |||||
2014-06-13 | 2014-06-11 | 4 | Ekman Lars | OCRX | Stock Option (Right to Buy) | D | 7,84 | 10 000 | 10 000 | |||||
2014-06-13 | 2014-06-11 | 4 | Kjellson Nina S | OCRX | Stock Option (Right to Buy) | D | 7,84 | 10 000 | 10 000 | |||||
2014-06-13 | 2014-06-11 | 4 | Grais Linda S | OCRX | Stock Option (Right to Buy) | D | 7,84 | 75 000 | 75 000 | |||||
2014-06-13 | 2014-06-11 | 4 | Castaigne Jean-Paul | OCRX | Stock Option (Right to Buy) | D | 7,84 | 10 000 | 10 000 | |||||
2014-06-13 | 2014-06-11 | 4 | Aggarwal Gaurav | OCRX | Stock Option (Right to Buy) | D | 7,84 | 25 000 | 25 000 | |||||
2014-05-02 | 3 | Aggarwal Gaurav | OCRX | Common Stock | D | 5 000 | ||||||||
2014-05-02 | 3 | Aggarwal Gaurav | OCRX | Common Stock | D | 5 000 | ||||||||
2014-05-02 | 2014-04-30 | 4 | Aggarwal Gaurav | OCRX | Stock Option (Right to Buy | D | 8,26 | 175 000 | 175 000 | |||||
2014-03-20 | 2014-03-18 | 4 | POWELL MICHAEL | OCRX | Common Stock | I | −4 612 | 9 364 | ||||||
2014-03-20 | 2014-03-18 | 4 | POWELL MICHAEL | OCRX | Common Stock | I | −67 040 | 136 112 | ||||||
2014-03-20 | 2014-03-18 | 4 | POWELL MICHAEL | OCRX | Common Stock | I | −338 370 | 686 994 | ||||||
2014-03-20 | 2014-03-18 | 4 | SOFINNOVA VENTURE PARTNERS VI L P | OCRX | Common Stock | D | −4 612 | 9 364 | ||||||
2014-03-20 | 2014-03-18 | 4 | SOFINNOVA VENTURE PARTNERS VI L P | OCRX | Common Stock | D | −67 040 | 136 112 | ||||||
2014-03-20 | 2014-03-18 | 4 | SOFINNOVA VENTURE PARTNERS VI L P | OCRX | Common Stock | D | −338 370 | 686 994 | ||||||
2013-12-23 | 2013-09-03 | 4 | HILLEMAN JERYL L | OCRX | Stock Option (Right to Buy) | D | 7,95 | 200 000 | 200 000 | |||||
2013-12-23 | 2013-08-13 | 4 | ROUSSEAU FRANCK | OCRX | Stock Option (Right to Buy) | D | 7,38 | 226 000 | 226 000 | |||||
2013-12-23 | 2013-08-30 | 4 | POWELL MICHAEL | OCRX | Stock Option (Right to Buy) | D | 7,85 | 20 000 | 20 000 | |||||
2013-12-23 | 2013-08-30 | 4 | VANLENT ANNE | OCRX | Stock Option (Right to Buy) | D | 7,85 | 20 000 | 20 000 | |||||
2013-12-23 | 2013-12-19 | 4 | WIERENGA WENDALL | OCRX | Stock Option (Right to Buy) | D | 13,25 | 20 000 | 20 000 | |||||
2013-12-23 | 2013-08-30 | 4 | WEBER ECKARD | OCRX | Stock Option (Right to Buy) | D | 7,85 | 20 000 | 20 000 | |||||
2013-12-23 | 2013-08-30 | 4 | Ekman Lars | OCRX | Stock Option (Right to Buy) | D | 7,85 | 20 000 | 20 000 | |||||
2013-12-23 | 2013-08-30 | 4 | Kjellson Nina S | OCRX | Stock Option (Right to Buy) | D | 7,85 | 20 000 | 20 000 | |||||
2013-12-23 | 2013-08-13 | 4 | Grais Linda S | OCRX | Stock Option (Right to Buy) | D | 7,38 | 491 550 | 491 550 | |||||
2013-12-23 | 2013-08-30 | 4 | Castaigne Jean-Paul | OCRX | Stock Option (Right to Buy) | D | 7,85 | 20 000 | 20 000 | |||||
2013-12-23 | 2013-08-30 | 4 | Shah Pratik | OCRX | Stock Option (Right to Buy) | D | 7,85 | 20 000 | 20 000 | |||||
2013-11-12 | 2013-11-08 | 4 | Kjellson Nina S By Partnership | OCRX | Warrant | I | 7,66 | 84 448 | 84 448 | |||||
2013-11-12 | 2013-11-08 | 4 | Kjellson Nina S By Partnership | OCRX | Common Stock | I | 422 238 | 1 248 064 | ||||||
2013-07-31 | 3/A | BLAIR JAMES C By DP VI Associates, L.P. | OCRX | Common Stock | I | 15 731 | ||||||||
2013-07-31 | 3/A | BLAIR JAMES C By Domain Partners VI, L.P. | OCRX | Common Stock | I | 1 525 163 | ||||||||
2013-07-31 | 3/A | BLAIR JAMES C By Domain Associates, LLC | OCRX | Common Stock | I | 47 963 | ||||||||
2013-07-31 | 2013-07-15 | 4/A | BLAIR JAMES C By Domain Partners VI, L.P. | OCRX | Common Stock | I | 6,0264 | 331 873 | 2 000 | 1 857 036 | ||||
2013-07-31 | 2013-07-15 | 4/A | BLAIR JAMES C By DP VIII Associates, L.P. | OCRX | Common Stock | I | 6,0264 | 7 333 | 44 | 7 333 | ||||
2013-07-31 | 2013-07-15 | 4/A | BLAIR JAMES C By Domain Partners VIII, L.P. | OCRX | Common Stock | I | 6,0264 | 988 285 | 5 956 | 988 285 | ||||
2013-07-31 | 3/A | DOVEY BRIAN H By Domain Partners VI, L.P. | OCRX | Common Stock | I | 1 525 163 | ||||||||
2013-07-31 | 3/A | DOVEY BRIAN H By DP VI Associates, L.P. | OCRX | Common Stock | I | 15 731 | ||||||||
2013-07-31 | 3/A | DOVEY BRIAN H By Domain Associates, LLC | OCRX | Common Stock | I | 47 963 | ||||||||
2013-07-31 | 2013-07-15 | 4/A | DOVEY BRIAN H By Domain Partners VI, L.P. | OCRX | Common Stock | I | 6,0264 | 331 873 | 2 000 | 1 857 036 | ||||
2013-07-31 | 2013-07-15 | 4/A | DOVEY BRIAN H By DP VIII Associates, L.P. | OCRX | Common Stock | I | 6,0264 | 7 333 | 44 | 7 333 | ||||
2013-07-31 | 2013-07-15 | 4/A | DOVEY BRIAN H By Domain Partners VIII, L.P. | OCRX | Common Stock | I | 6,0264 | 988 285 | 5 956 | 988 285 | ||||
2013-07-31 | 3/A | SCHOEMAKER KATHLEEN K By Domain Partners VI, L.P. | OCRX | Common Stock | I | 1 525 163 | ||||||||
2013-07-31 | 3/A | SCHOEMAKER KATHLEEN K By Domain Associates, LLC | OCRX | Common Stock | I | 47 963 | ||||||||
2013-07-31 | 3/A | SCHOEMAKER KATHLEEN K By DP VI Associates, L.P. | OCRX | Common Stock | I | 15 731 | ||||||||
2013-07-31 | 2013-07-15 | 4/A | SCHOEMAKER KATHLEEN K By Domain Partners VI, L.P. | OCRX | Common Stock | I | 6,0264 | 331 873 | 2 000 | 1 857 036 | ||||
2013-07-31 | 2013-07-15 | 4/A | SCHOEMAKER KATHLEEN K By DP VIII Associates, L.P. | OCRX | Common Stock | I | 6,0264 | 7 333 | 44 | 7 333 | ||||
2013-07-31 | 2013-07-15 | 4/A | SCHOEMAKER KATHLEEN K By Domain Partners VIII, L.P. | OCRX | Common Stock | I | 6,0264 | 988 285 | 5 956 | 988 285 | ||||
2013-07-31 | 3/A | TREU JESSE I By DP VI Associates, L.P. | OCRX | Common Stock | I | 15 731 | ||||||||
2013-07-31 | 3/A | TREU JESSE I By Domain Associates, LLC | OCRX | Common Stock | I | 47 963 | ||||||||
2013-07-31 | 3/A | TREU JESSE I By Domain Partners VI, L.P. | OCRX | Common Stock | I | 1 525 163 | ||||||||
2013-07-31 | 2013-07-15 | 4/A | TREU JESSE I By Domain Partners VI, L.P. | OCRX | Common Stock | I | 6,0264 | 331 873 | 2 000 | 1 857 036 | ||||
2013-07-31 | 2013-07-15 | 4/A | TREU JESSE I By DP VIII Associates, L.P. | OCRX | Common Stock | I | 6,0264 | 7 333 | 44 | 7 333 | ||||
2013-07-31 | 2013-07-15 | 4/A | TREU JESSE I By Domain Partners VIII, L.P. | OCRX | Common Stock | I | 6,0264 | 988 285 | 5 956 | 988 285 | ||||
2013-07-31 | 3/A | Domain Partners VI, L.P. | OCRX | Common Stock | D | 1 525 163 | ||||||||
2013-07-31 | 2013-07-15 | 4/A | Domain Partners VI, L.P. | OCRX | Common Stock | D | 6,0264 | 331 873 | 2 000 | 1 857 036 | ||||
2013-07-31 | 3/A | VITULLO NICOLE By DP VI Associates, L.P. | OCRX | Common Stock | I | 15 731 | ||||||||
2013-07-31 | 3/A | VITULLO NICOLE By Domain Partners VI, L.P. | OCRX | Common Stock | I | 1 525 163 | ||||||||
2013-07-31 | 3/A | VITULLO NICOLE By Domain Associates, LLC | OCRX | Common Stock | I | 47 963 | ||||||||
2013-07-31 | 2013-07-15 | 4/A | VITULLO NICOLE By Domain Partners VI, L.P. | OCRX | Common Stock | I | 6,0264 | 331 873 | 2 000 | 1 857 036 | ||||
2013-07-31 | 2013-07-15 | 4/A | VITULLO NICOLE By DP VIII Associates, L.P. | OCRX | Common Stock | I | 6,0264 | 7 333 | 44 | 7 333 | ||||
2013-07-31 | 2013-07-15 | 4/A | VITULLO NICOLE By Domain Partners VIII, L.P. | OCRX | Common Stock | I | 6,0264 | 988 285 | 5 956 | 988 285 | ||||
2013-07-25 | 2013-07-15 | 4/A | Halak Brian K By DP VIII Associates, L.P. | OCRX | Common Stock | I | 6,0264 | 7 333 | 44 | 7 333 | ||||
2013-07-25 | 2013-07-15 | 4/A | Halak Brian K By Domain Partners VIII, L.P. | OCRX | Common Stock | I | 6,0264 | 988 285 | 5 956 | 988 285 | ||||
2013-07-25 | 3/A | Halak Brian K By Domain Associates, LLC | OCRX | Common Stock | I | 47 963 | ||||||||
2013-07-24 | 3 | AGUIAR ERIC See footnotes | OCRX | Common Stock, par value $0.00001 per share | I | 1 751 393 | ||||||||
2013-07-24 | 3 | AGUIAR ERIC | OCRX | Common Stock, par value $0.00001 per share | D | 687 176 | ||||||||
2013-07-17 | 2013-07-15 | 4/A | Zisson Alex see footnotes | OCRX | Common Stock, par value $0.00001 per share | I | 6,0000 | 2 500 002 | 15 000 | 2 500 002 | ||||
2013-07-17 | 2012-08-07 | 4/A | Zisson Alex | OCRX | Stock Option (Right to Buy) | D | 4,24 | 31 835 | 31 835 | |||||
2013-07-17 | 2011-04-19 | 4/A | Zisson Alex | OCRX | Stock Option (Right to Buy) | D | 4,00 | 25 000 | 25 000 | |||||
2013-07-17 | 2013-07-15 | 4/A | Thomas, McNerney & Partners II L.P. See footnotes | OCRX | Common Stock, par value $0.00001 per share | I | 6,0000 | 1 751 393 | 10 508 | 1 751 393 | ||||
2013-07-17 | 2013-07-15 | 4/A | Thomas, McNerney & Partners II L.P. | OCRX | Common Stock, par value $0.00001 per share | D | 6,0000 | 687 176 | 4 123 | 687 176 | ||||
2013-07-17 | 2012-10-01 | 4/A | Thomas, McNerney & Partners II L.P. See footnotes | OCRX | Warrants | I | 0,08 | 44,2300 | 161 855 | 7 159 | 161 855 | |||
2013-07-17 | 2012-08-07 | 4/A | Thomas, McNerney & Partners II L.P. See footnotes | OCRX | Stock Option (Right to Buy) | I | 4,24 | 31 835 | 31 835 | |||||
2013-07-17 | 2012-03-30 | 4/A | Thomas, McNerney & Partners II L.P. See footnotes | OCRX | Warrants | I | 0,08 | 44,2300 | 161 855 | 7 159 | 161 855 | |||
2013-07-17 | 2011-04-19 | 4/A | Thomas, McNerney & Partners II L.P. See footnotes | OCRX | Stock Option (Right to Buy) | I | 4,00 | 25 000 | 25 000 | |||||
2013-07-17 | 2010-02-11 | 4/A | Thomas, McNerney & Partners II L.P. See footnotes | OCRX | Stock Option (Right to Buy) | I | 0,22 | 25 000 | 25 000 | |||||
2013-07-17 | 2009-02-11 | 4/A | Thomas, McNerney & Partners II L.P. See footnotes | OCRX | Stock Option (Right to Buy) | I | 0,22 | 25 000 | 25 000 | |||||
2013-07-17 | 2006-02-06 | 4/A | Thomas, McNerney & Partners II L.P. See footnotes | OCRX | Stock Option (Right to Buy) | I | 0,11 | 100 000 | 100 000 | |||||
2013-07-17 | 2013-07-15 | 4/A | THOMAS MCNERNEY & PARTNERS LP See footnotes | OCRX | Common Stock, par value $0.00001 per share | I | 6,0000 | 762 892 | 4 577 | 762 892 | ||||
2013-07-17 | 2013-07-15 | 4/A | THOMAS MCNERNEY & PARTNERS LP | OCRX | Common Stock, par value $0.00001 per share | D | 6,0000 | 1 675 677 | 10 054 | 1 675 677 | ||||
2013-07-17 | 2012-10-01 | 4/A | THOMAS MCNERNEY & PARTNERS LP | OCRX | Warrants | I | 0,08 | 44,2300 | 161 855 | 7 159 | 161 855 | |||
2013-07-17 | 2012-08-07 | 4/A | THOMAS MCNERNEY & PARTNERS LP | OCRX | Stock Option (Right to Buy) | I | 4,24 | 31 835 | 31 835 | |||||
2013-07-17 | 2012-03-30 | 4/A | THOMAS MCNERNEY & PARTNERS LP | OCRX | Warrants | I | 0,08 | 44,2300 | 161 855 | 7 159 | 161 855 | |||
2013-07-17 | 2011-04-19 | 4/A | THOMAS MCNERNEY & PARTNERS LP | OCRX | Stock Option (Right to Buy) | I | 4,00 | 25 000 | 25 000 | |||||
2013-07-17 | 2010-02-11 | 4/A | THOMAS MCNERNEY & PARTNERS LP | OCRX | Stock Option (Right to Buy) | I | 0,22 | 25 000 | 25 000 | |||||
2013-07-17 | 2009-02-11 | 4/A | THOMAS MCNERNEY & PARTNERS LP | OCRX | Stock Option (Right to Buy) | I | 0,22 | 25 000 | 25 000 | |||||
2013-07-17 | 2006-02-06 | 4/A | THOMAS MCNERNEY & PARTNERS LP | OCRX | Stock Option (Right to Buy) | I | 0,11 | 100 000 | 100 000 | |||||
2013-07-17 | 2013-07-15 | 4 | POWELL MICHAEL | OCRX | Stock warrant (right to buy) | I | 0,67 | 125 | 125 | |||||
2013-07-17 | 2013-07-15 | 4 | POWELL MICHAEL | OCRX | Stock warrant (right to buy) | I | 0,67 | 125 | 125 | |||||
2013-07-17 | 2013-07-15 | 4 | POWELL MICHAEL | OCRX | Stock warrant (right to buy) | I | 0,67 | 1 820 | 1 820 | |||||
2013-07-17 | 2013-07-15 | 4 | POWELL MICHAEL | OCRX | Stock warrant (right to buy) | I | 0,67 | 1 820 | 1 820 | |||||
2013-07-17 | 2013-07-15 | 4 | POWELL MICHAEL | OCRX | Stock warrant (right to buy) | I | 0,67 | 9 187 | 9 187 | |||||
2013-07-17 | 2013-07-15 | 4 | POWELL MICHAEL | OCRX | Stock warrant (right to buy) | I | 0,67 | 9 187 | 9 187 | |||||
2013-07-17 | 2013-07-15 | 4 | POWELL MICHAEL | OCRX | Stock option (right to buy) | D | 1,84 | 2 992 | 2 992 | |||||
2013-07-17 | 2013-07-15 | 4 | POWELL MICHAEL | OCRX | Stock option (right to buy) | D | 1,84 | 2 992 | 2 992 | |||||
2013-07-17 | 2013-07-15 | 4 | POWELL MICHAEL | OCRX | Stock option (right to buy) | D | 1,25 | 11 969 | 11 969 | |||||
2013-07-17 | 2013-07-15 | 4 | POWELL MICHAEL | OCRX | Common Stock | I | 6,0264 | 4 400 | 27 | 13 976 | ||||
2013-07-17 | 2013-07-15 | 4 | POWELL MICHAEL | OCRX | Common Stock | I | 9 576 | 9 576 | ||||||
2013-07-17 | 2013-07-15 | 4 | POWELL MICHAEL | OCRX | Common Stock | I | 6,0264 | 63 957 | 385 | 203 152 | ||||
2013-07-17 | 2013-07-15 | 4 | POWELL MICHAEL | OCRX | Common Stock | I | 139 195 | 139 195 | ||||||
2013-07-17 | 2013-07-15 | 4 | POWELL MICHAEL | OCRX | Common Stock | I | 6,0264 | 322 809 | 1 945 | 1 025 364 | ||||
2013-07-17 | 2013-07-15 | 4 | POWELL MICHAEL | OCRX | Common Stock | I | 702 555 | 702 555 | ||||||
2013-07-17 | 2013-07-15 | 4 | Ekman Lars | OCRX | Stock Option (right to buy) | D | 1,84 | 2 992 | 2 992 | |||||
2013-07-17 | 2013-07-15 | 4 | Ekman Lars | OCRX | Stock Option (right to buy) | D | 1,84 | 11 969 | 11 969 | |||||
2013-07-17 | 2013-07-15 | 4 | Kjellson Nina S By partnership | OCRX | NQ Stock Option (right to buy) | I | 1,84 | 2 992 | 2 992 | |||||
2013-07-17 | 2013-07-15 | 4 | Kjellson Nina S By partnership | OCRX | NQ Stock Option (right to buy) | I | 1,84 | 2 992 | 2 992 | |||||
2013-07-17 | 2013-07-15 | 4 | Kjellson Nina S By Partnership | OCRX | NQ Stock Option (right to buy) | I | 2,51 | 11 969 | 11 969 | |||||
2013-07-17 | 2013-07-15 | 4 | Kjellson Nina S By Partnership | OCRX | Warrant | I | 0,67 | 5 157 | 5 157 | |||||
2013-07-17 | 2013-07-15 | 4 | Kjellson Nina S By Partnership | OCRX | Warrant | I | 0,67 | 5 157 | 5 157 | |||||
2013-07-17 | 2013-07-15 | 4 | Kjellson Nina S By partnership | OCRX | Common Stock | I | 6,0264 | 431 435 | 2 600 | 825 826 | ||||
2013-07-17 | 2013-07-15 | 4 | Kjellson Nina S By partnership | OCRX | Common Stock | I | 394 391 | 394 391 | ||||||
2013-07-17 | 3 | HEALY JAMES | OCRX | Common Stock | D | 139 195 | ||||||||
2013-07-17 | 3 | HEALY JAMES | OCRX | Common Stock | D | 702 555 | ||||||||
2013-07-17 | 3 | HEALY JAMES | OCRX | Common Stock | D | 9 576 | ||||||||
2013-07-17 | 2013-07-15 | 4 | SOFINNOVA VENTURE PARTNERS VI L P | OCRX | Common Stock | D | 6,0264 | 4 400 | 27 | 13 976 | ||||
2013-07-17 | 2013-07-15 | 4 | SOFINNOVA VENTURE PARTNERS VI L P | OCRX | Common Stock | D | 6,0264 | 63 957 | 385 | 203 152 | ||||
2013-07-17 | 2013-07-15 | 4 | SOFINNOVA VENTURE PARTNERS VI L P | OCRX | Common Stock | D | 6,0264 | 322 809 | 1 945 | 1 025 364 | ||||
2013-07-17 | 2013-07-15 | 4 | Grais Linda S | OCRX | Employee stock option (right to buy) | D | 0,67 | 61 653 | 61 653 | |||||
2013-07-17 | 2013-07-15 | 4 | Grais Linda S | OCRX | Employee stock option (right to buy) | D | 0,67 | 11 969 | 11 969 | |||||
2013-07-17 | 3 | Shah Pratik See footnotes | OCRX | Common Stock, par value $0.00001 per share | I | 2 500 002 | ||||||||
2013-07-16 | 3 | DOMAIN ASSOCIATES | OCRX | Common Stock | D | 47 963 | ||||||||
2013-07-16 | 3 | DOVEY BRIAN H By DP VI Associates, L.P. | OCRX | Common Stock | I | 15 731 | ||||||||
2013-07-16 | 3 | DOVEY BRIAN H By Domain Associates, LLC | OCRX | Common Stock | I | 47 963 | ||||||||
2013-07-16 | 3 | DOVEY BRIAN H By Domain Partners VI, L.P. | OCRX | Common Stock | I | 1 565 463 | ||||||||
2013-07-16 | 3 | BLAIR JAMES C By Domain Partners VI, L.P. | OCRX | Common Stock | I | 1 565 463 | ||||||||
2013-07-16 | 3 | BLAIR JAMES C By DP VI Associates, L.P. | OCRX | Common Stock | I | 15 731 | ||||||||
2013-07-16 | 3 | BLAIR JAMES C By Domain Associates, LLC | OCRX | Common Stock | I | 47 963 | ||||||||
2013-07-16 | 3 | TREU JESSE I By DP VI Associates, L.P. | OCRX | Common Stock | I | 15 731 | ||||||||
2013-07-16 | 3 | TREU JESSE I By Domain Associates, LLC | OCRX | Common Stock | I | 47 963 | ||||||||
2013-07-16 | 3 | TREU JESSE I By Domain Partners VI, L.P. | OCRX | Common Stock | I | 1 565 463 | ||||||||
2013-07-16 | 3 | SCHOEMAKER KATHLEEN K By DP VI Associates, L.P. | OCRX | Common Stock | I | 15 731 | ||||||||
2013-07-16 | 3 | SCHOEMAKER KATHLEEN K By Domain Associates, LLC | OCRX | Common Stock | I | 47 963 | ||||||||
2013-07-16 | 3 | SCHOEMAKER KATHLEEN K By Domain Partners VI, L.P. | OCRX | Common Stock | I | 1 565 463 | ||||||||
2013-07-16 | 3 | VITULLO NICOLE By DP VI Associates, L.P. | OCRX | Common Stock | I | 15 731 | ||||||||
2013-07-16 | 3 | VITULLO NICOLE By Domain Partners VI, L.P. | OCRX | Common Stock | I | 1 565 463 | ||||||||
2013-07-16 | 3 | VITULLO NICOLE By Domain Associates, LLC | OCRX | Common Stock | I | 47 963 | ||||||||
2013-07-16 | 2013-07-15 | 4 | TREU JESSE I By Domain Partners VI, L.P. | OCRX | Common Stock | I | 6,0264 | 331 873 | 2 000 | 1 897 336 | ||||
2013-07-16 | 2013-07-15 | 4 | TREU JESSE I By DP VIII Associates, L.P. | OCRX | Common Stock | I | 6,0264 | 7 333 | 44 | 7 333 | ||||
2013-07-16 | 2013-07-15 | 4 | TREU JESSE I By Domain Partners VIII, L.P. | OCRX | Common Stock | I | 6,0264 | 988 285 | 5 956 | 988 285 | ||||
2013-07-16 | 2013-07-15 | 4 | VITULLO NICOLE By Domain Partners VI, L.P. | OCRX | Common Stock | I | 6,0264 | 331 873 | 2 000 | 1 897 336 | ||||
2013-07-16 | 2013-07-15 | 4 | VITULLO NICOLE By DP VIII Associates, L.P. | OCRX | Common Stock | I | 6,0264 | 7 333 | 44 | 7 333 | ||||
2013-07-16 | 2013-07-15 | 4 | VITULLO NICOLE By Domain Partners VIII, L.P. | OCRX | Common Stock | I | 6,0264 | 988 285 | 5 956 | 988 285 | ||||
2013-07-16 | 2013-07-15 | 4 | BLAIR JAMES C By Domain Partners VI, L.P. | OCRX | Common Stock | I | 6,0264 | 331 873 | 2 000 | 1 897 336 | ||||
2013-07-16 | 2013-07-15 | 4 | BLAIR JAMES C By DP VIII Associates, L.P. | OCRX | Common Stock | I | 6,0264 | 7 333 | 44 | 7 333 | ||||
2013-07-16 | 2013-07-15 | 4 | BLAIR JAMES C By Domain Partners VIII, L.P. | OCRX | Common Stock | I | 6,0264 | 988 285 | 5 956 | 988 285 | ||||
2013-07-16 | 2013-07-15 | 4 | SCHOEMAKER KATHLEEN K By Domain Partners VI, L.P. | OCRX | Common Stock | I | 6,0264 | 331 873 | 2 000 | 1 897 336 | ||||
2013-07-16 | 2013-07-15 | 4 | SCHOEMAKER KATHLEEN K By DP VIII Associates, L.P. | OCRX | Common Stock | I | 6,0264 | 7 333 | 44 | 7 333 | ||||
2013-07-16 | 2013-07-15 | 4 | SCHOEMAKER KATHLEEN K By Domain Partners VIII, L.P. | OCRX | Common Stock | I | 6,0264 | 988 285 | 5 956 | 988 285 | ||||
2013-07-16 | 2013-07-15 | 4 | DOVEY BRIAN H By Domain Partners VI, L.P. | OCRX | Common Stock | I | 6,0264 | 331 873 | 2 000 | 1 897 336 | ||||
2013-07-16 | 2013-07-15 | 4 | DOVEY BRIAN H By DP VIII Associates, L.P. | OCRX | Common Stock | I | 6,0264 | 7 333 | 44 | 7 333 | ||||
2013-07-16 | 2013-07-15 | 4 | DOVEY BRIAN H By Domain Partners VIII, L.P. | OCRX | Common Stock | I | 6,0264 | 988 285 | 5 956 | 988 285 | ||||
2013-07-16 | 2013-07-15 | 4 | WEBER ECKARD | OCRX | Stock Option (right to buy) | D | 1,84 | 2 992 | 2 992 | |||||
2013-07-16 | 2013-07-15 | 4 | WEBER ECKARD | OCRX | Stock Option (right to buy) | D | 1,84 | 2 992 | 2 992 | |||||
2013-07-16 | 2013-07-15 | 4 | WEBER ECKARD | OCRX | Stock Option (right to buy) | D | 0,92 | 11 969 | 11 969 | |||||
2013-07-16 | 2013-07-15 | 4 | WEBER ECKARD | OCRX | Common Stock | D | 344 719 | 344 719 | ||||||
2013-07-16 | 3 | Domain Partners VI, L.P. | OCRX | Common Stock | D | 1 565 463 | ||||||||
2013-07-16 | 2013-07-15 | 4 | Domain Partners VI, L.P. | OCRX | Common Stock | D | 6,0264 | 331 873 | 2 000 | 1 897 336 | ||||
2013-07-16 | 3 | DP VI Associates, L.P. | OCRX | Common Stock | D | 15 731 | ||||||||
2013-07-16 | 3 | Halak Brian K By Domain Associates, LLC | OCRX | Common Stock | I | 47 963 | ||||||||
2013-07-16 | 3 | Halak Brian K By Domain Partners VI, L.P. | OCRX | Common Stock | I | 1 565 463 | ||||||||
2013-07-16 | 3 | Halak Brian K By DP VI Associates, L.P. | OCRX | Common Stock | I | 15 731 | ||||||||
2013-07-16 | 2013-07-15 | 4 | Halak Brian K By Domain Partners VI, L.P. | OCRX | Common Stock | I | 6,0264 | 331 873 | 2 000 | 1 897 336 | ||||
2013-07-16 | 2013-07-15 | 4 | Halak Brian K By DP VIII Associates, L.P. | OCRX | Common Stock | I | 6,0264 | 7 333 | 44 | 7 333 | ||||
2013-07-16 | 2013-07-15 | 4 | Halak Brian K By Domain Partners VIII, L.P. | OCRX | Common Stock | I | 6,0264 | 988 285 | 5 956 | 988 285 | ||||
2013-07-16 | 3 | Kjellson Nina S | OCRX | No securities are beneficially owned | D | 0 | ||||||||
2013-07-16 | 3 | DP VIII Associates, L.P. | OCRX | Common Stock | D | 7 333 | ||||||||
2013-07-16 | 3 | Domain Partners VIII, L.P. | OCRX | Common Stock | D | 988 285 | ||||||||
2013-07-16 | 3 | Kamdar Kim P. By Domain Associates, LLC | OCRX | Common Stock | I | 47 963 | ||||||||
2013-07-16 | 2013-07-15 | 4 | McGowan Dana S. | OCRX | Employee stock option (right to buy) | D | 0,67 | 4 818 | 4 818 | |||||
2013-07-16 | 2013-07-15 | 4 | McGowan Dana S. | OCRX | Employee stock option (right to buy) | D | 0,67 | 8 683 | 8 683 | |||||
2013-07-16 | 2013-07-15 | 4 | McGowan Dana S. | OCRX | Employee stock option (right to buy) | D | 1,84 | 5 984 | 5 984 | |||||
2013-07-16 | 2013-07-15 | 4 | McGowan Dana S. | OCRX | Employee stock option (right to buy) | D | 1,84 | 5 984 | 5 984 | |||||
2013-07-16 | 2013-07-15 | 4 | McGowan Dana S. | OCRX | Employee stock option (right to buy) | D | 1,84 | 5 330 | 5 330 | |||||
2013-07-16 | 2013-07-15 | 4 | McGowan Dana S. | OCRX | Employee stock option (right to buy) | D | 2,51 | 4 488 | 4 488 | |||||
2013-07-16 | 2013-07-15 | 4 | McGowan Dana S. | OCRX | Employee stock option (right to buy) | D | 1,25 | 17 954 | 17 954 | |||||
2013-07-16 | 2013-07-15 | 4 | McGowan Dana S. | OCRX | Employee stock option (right to buy) | D | 0,84 | 14 680 | 14 680 | |||||
2013-07-15 | 3 | POWELL MICHAEL | TZYM | No securities are beneficially owned | D | 0 | ||||||||
2012-08-09 | 2012-08-07 | 4 | ROUSSEAU FRANCK | TZYM | Employee Stock Option (Right to Buy) | D | 4,24 | 8 000 | 8 000 | |||||
2012-08-09 | 2012-08-07 | 4 | VANLENT ANNE | TZYM | Stock Option (Right to Buy) | D | 4,24 | 31 835 | 31 835 | |||||
2012-08-09 | 2012-08-07 | 4 | JOHNSON JOHN | TZYM | Stock Option (Right to Buy) | D | 4,24 | 21 044 | 21 044 | |||||
2012-08-09 | 2012-08-07 | 4 | ABERCROMBIE GEORGE B | TZYM | Stock Option (Right to Buy) | D | 4,24 | 31 835 | 31 835 | |||||
2012-08-09 | 2012-08-07 | 4 | Zisson Alex | TZYM | Stock Option (Right to Buy) | D | 4,24 | 31 835 | 31 835 | |||||
2012-08-09 | 2012-08-07 | 4 | Thomas Helmut | TZYM | Employee Stock Option (Right to Buy) | D | 4,24 | 90 000 | 90 000 | |||||
2012-08-09 | 2012-08-07 | 4 | Castaigne Jean-Paul | TZYM | Stock Option (Right to Buy) | D | 4,24 | 26 448 | 26 448 | |||||
2012-08-09 | 2012-08-07 | 4 | Eisenstadt Richard I | TZYM | Employee Stock Option (Right to Buy) | D | 4,24 | 40 000 | 40 000 | |||||
2012-08-09 | 2012-08-07 | 4 | Garg Vipin K | TZYM | Employee Stock Option (Right to Buy) | D | 4,24 | 50 000 | 50 000 | |||||
2012-08-09 | 2012-08-07 | 4 | Davidson Aaron | TZYM | Stock Option (Right to Buy) | D | 4,24 | 31 835 | 31 835 | |||||
2012-04-23 | 2012-04-19 | 4 | ROUSSEAU FRANCK | TZYM | Employee Stock Option (Right to Buy) | D | 3,09 | 100 000 | 100 000 | |||||
2012-04-23 | 2012-04-19 | 4 | Moore David | TZYM | Employee Stock Option (Right to Buy) | D | 3,09 | 50 000 | 50 000 | |||||
2012-03-14 | 3 | BAKER FELIX Through Partnership | TZYM | Common Stock | I | 110 030 | ||||||||
2012-03-14 | 2012-03-14 | 4 | Baker Biotech Capital (GP), LLC Through Partnership | TZYM | Common Stock | I | 3,0055 | 4 592 | 14 | 232 011 | ||||
2012-03-14 | 2012-03-14 | 4 | Baker Biotech Capital (GP), LLC Through Partnership | TZYM | Common Stock | I | 2,9891 | 7 484 | 22 | 227 419 | ||||
2012-03-14 | 2012-03-13 | 4 | Baker Biotech Capital (GP), LLC Through Partnership | TZYM | Common Stock | I | 2,9581 | 15 599 | 46 | 219 935 | ||||
2012-03-14 | 2012-03-12 | 4 | Baker Biotech Capital (GP), LLC Through Partnership | TZYM | Common Stock | I | 2,5500 | 56 187 | 143 | 204 336 | ||||
2012-03-14 | 2012-03-12 | 4 | Baker Biotech Capital (GP), LLC Through Partnership | TZYM | Common Stock | I | 2,3396 | 32 155 | 75 | 148 149 | ||||
2012-03-14 | 2012-03-12 | 4 | Baker Biotech Capital (GP), LLC Through Partnership | TZYM | Common Stock | I | 1,8700 | 4 363 | 8 | 115 994 | ||||
2012-03-14 | 2012-03-12 | 4 | Baker Biotech Capital (GP), LLC Through Partnership | TZYM | Common Stock | I | 1,8858 | 1 601 | 3 | 111 631 | ||||
2012-03-14 | 3 | BAKER JULIAN Through Partnership | TZYM | Common Stock | I | 2 328 863 | ||||||||
2012-03-14 | 2012-03-14 | 4 | Baker Brothers Life Sciences Capital (GP), LLC Through Partnership | TZYM | Common Stock | I | 3,0055 | 34 544 | 104 | 3 540 015 | ||||
2012-03-14 | 2012-03-14 | 4 | Baker Brothers Life Sciences Capital (GP), LLC Through Partnership | TZYM | Common Stock | I | 2,9891 | 56 294 | 168 | 3 505 471 | ||||
2012-03-14 | 2012-03-13 | 4 | Baker Brothers Life Sciences Capital (GP), LLC Through Partnership | TZYM | Common Stock | I | 2,9581 | 159 015 | 470 | 3 449 177 | ||||
2012-03-14 | 2012-03-12 | 4 | Baker Brothers Life Sciences Capital (GP), LLC Through Partnership | TZYM | Common Stock | I | 2,5500 | 572 737 | 1 460 | 3 290 162 | ||||
2012-03-14 | 2012-03-12 | 4 | Baker Brothers Life Sciences Capital (GP), LLC Through Partnership | TZYM | Common Stock | I | 2,3396 | 327 769 | 767 | 2 717 425 | ||||
2012-03-14 | 2012-03-12 | 4 | Baker Brothers Life Sciences Capital (GP), LLC Through Partnership | TZYM | Common Stock | I | 1,8700 | 44 467 | 83 | 2 389 656 | ||||
2012-03-14 | 2012-03-12 | 4 | Baker Brothers Life Sciences Capital (GP), LLC Through Partnership | TZYM | Common Stock | I | 1,8858 | 16 326 | 31 | 2 345 189 | ||||
2012-03-14 | 3 | BAKER FELIX Through Partnership | TZYM | Common Stock | I | 25 822 | ||||||||
2012-03-14 | 2012-03-14 | 4 | 14159 capital (GP), LLC Through Partnership | TZYM | Common Stock | I | 3,0055 | 910 | 3 | 57 704 | ||||
2012-03-14 | 2012-03-14 | 4 | 14159 capital (GP), LLC Through Partnership | TZYM | Common Stock | I | 2,9891 | 1 482 | 4 | 56 794 | ||||
2012-03-14 | 2012-03-13 | 4 | 14159 capital (GP), LLC Through Partnership | TZYM | Common Stock | I | 2,9581 | 4 186 | 12 | 55 312 | ||||
2012-03-14 | 2012-03-12 | 4 | 14159 capital (GP), LLC Through Partnership | TZYM | Common Stock | I | 2,5500 | 15 076 | 38 | 51 126 | ||||
2012-03-14 | 2012-03-12 | 4 | 14159 capital (GP), LLC Through Partnership | TZYM | Common Stock | I | 2,3396 | 8 628 | 20 | 36 050 | ||||
2012-03-14 | 2012-03-12 | 4 | 14159 capital (GP), LLC Through Partnership | TZYM | Common Stock | I | 1,8700 | 1 170 | 2 | 27 422 | ||||
2012-03-14 | 2012-03-12 | 4 | 14159 capital (GP), LLC Through Partnership | TZYM | Common Stock | I | 1,8858 | 430 | 1 | 26 252 |